Virus-induced endothelial senescence as a cause and driving factor for ME/CFS and long COVID: mediated by a dysfunctional immune system.
Nunes, Massimo, Kell, Loren, Slaghekke, Anouk et al. · Cell death & disease · 2026 · DOI
Quick Summary
This study proposes that ME/CFS and long COVID may be caused by damage to the blood vessels (endothelial cells) that occurs after a viral infection. When these cells become damaged and 'senescent' (aged), they release harmful substances that cause inflammation, blood clots, and reduced blood flow to the brain and other organs. The study suggests that a faulty immune system keeps these damaged blood vessels from healing, which is why symptoms persist for months or years after the initial infection.
Why It Matters
This study provides a unifying biological mechanism that could explain why ME/CFS and long COVID share so many symptoms and why they persist so long. If endothelial senescence and immune dysfunction are indeed central to disease pathology, it opens new avenues for identifying biomarkers and developing targeted treatments that address the root cause rather than just symptoms.
Observed Findings
Patients with ME/CFS and long COVID show reduced cerebral blood flow and impaired perfusion in various brain regions
Dysregulated inflammatory processes and immune abnormalities are documented in both ME/CFS and long COVID
Post-exertional malaise, fatigue, and gastrointestinal disturbances are common multisystem features of both conditions
Endothelial senescence induces a pro-inflammatory, pro-oxidative, procoagulant secretory phenotype (SASP)
Inferred Conclusions
Acute viral infection initiates endothelial dysfunction and senescence that can explain multisystem symptoms in ME/CFS and long COVID
Immune abnormalities prevent clearance of senescent endothelial cells, sustaining chronic disease pathology beyond the acute phase
Bidirectional cross-talk between immune dysregulation and endothelial senescence maintains disease perpetuation
Endothelial cell dysfunction should be considered a core pathological element in ME/CFS and long COVID disease mechanisms
Remaining Questions
What specific viral mechanisms trigger endothelial senescence, and why do some infected individuals develop persistent senescence while others recover?
How exactly do immune abnormalities in ME/CFS prevent clearance of senescent endothelial cells—which immune cell types and pathways are involved?
What This Study Does Not Prove
This is a theoretical framework paper, not an empirical study with patient data or experimental validation. It does not prove that endothelial senescence causes ME/CFS, only proposes a plausible mechanism. Direct evidence linking virus-induced endothelial senescence to persistent immune dysregulation and clinical symptoms in ME/CFS patients remains to be established through prospective studies.
Can biomarkers of endothelial senescence (circulating senescent cells, SASP factors) be validated as diagnostic or prognostic markers in longitudinal patient cohorts?
Which therapeutic interventions targeting endothelial senescence or immune dysfunction would be most effective, and in which patient subgroups?